Company · Ownership research

Olema Pharmaceuticals, Inc. OLMA

CIK 0001750284

Form 4 transactions dated Nov 1, 2023 to Nov 10, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

Insider filings on file run through Sep 2, 2026.

Some filings are submitted jointly by several insiders. The SEC form does not apportion the reported figures between them, so results include every joint filer.

Insider purchases & sales

Purchased: $4.76M
Sold: $84.36M

Nov 1, 2023 – Sep 2, 2026
Available records · partial months are marked ·

2023, from Nov 1, 202310 of 19 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Dec 29, 2023	Harmon Cyrus Director	Sale10b5-1 footnote	$334.50K 25,000 shares sold	2.70% sold Direct holding	▾
Dec 6, 2023	Paradigm BioCapital International Fund Ltd. · Paradigm Biocapital Advisors LP · Paradigm BioCapital Advisors GP LLC · Asefaw Senai 10% owner	Purchase	$1.16M 100,000 shares bought	Unavailable Indirect holding	▾
Dec 5, 2023	Graham G. Walmsley Director	Purchase	$1.87M 131,870 shares bought	7.91% added Indirect holding	▾
Nov 30, 2023	Harmon Cyrus Director	Sale10b5-1 footnote	$314.25K 25,000 shares sold	2.63% sold Direct holding	▾
Nov 22, 2023	Zojwalla Naseem CHIEF MEDICAL OFFICER	Sale	$98.55K 7,095 shares sold	18.79% sold Direct holding	▾
Nov 22, 2023	Myles David C. CH. DISCOV. & NON-CLIN DEV OFF	Sale	$92.41K 6,653 shares sold	1.15% sold Direct holding	▾
Nov 22, 2023	Harmon Cyrus Director	Sale	$55.45K 3,989 shares sold	0.42% sold Direct holding	▾
Nov 22, 2023	Bohen Sean PRESIDENT AND CEO · Director	Sale	$388.25K 27,932 shares sold	16.16% sold Direct holding	▾
Nov 22, 2023	Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.	Sale	$127.02K 9,145 shares sold	2.11% sold Direct holding	▾
Nov 21, 2023	Zojwalla Naseem CHIEF MEDICAL OFFICER	Sale	$110.75K 7,461 shares sold	16.50% sold Direct holding	▾

Showing 19 / 19 record groups in 2023. The complete set is available through the API.

Olema Pharmaceuticals, Inc. · OLMA

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 19 of 19 purchase / sale groups and 11 of 11 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"OLMA","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.